CR20170601A - Formulaciones farmaceuticas que comprenden tenofovir y emtricitabina - Google Patents
Formulaciones farmaceuticas que comprenden tenofovir y emtricitabinaInfo
- Publication number
- CR20170601A CR20170601A CR20170601A CR20170601A CR20170601A CR 20170601 A CR20170601 A CR 20170601A CR 20170601 A CR20170601 A CR 20170601A CR 20170601 A CR20170601 A CR 20170601A CR 20170601 A CR20170601 A CR 20170601A
- Authority
- CR
- Costa Rica
- Prior art keywords
- emtricitabina
- pharmaceutical formulations
- include tenofovir
- tenofovir
- pharmaceutically acceptable
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229960004556 tenofovir Drugs 0.000 title 1
- SGOIRFVFHAKUTI-ZCFIWIBFSA-N tenofovir (anhydrous) Chemical compound N1=CN=C2N(C[C@@H](C)OCP(O)(O)=O)C=NC2=C1N SGOIRFVFHAKUTI-ZCFIWIBFSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- XQSPYNMVSIKCOC-NTSWFWBYSA-N Emtricitabine Chemical compound C1=C(F)C(N)=NC(=O)N1[C@H]1O[C@@H](CO)SC1 XQSPYNMVSIKCOC-NTSWFWBYSA-N 0.000 abstract 1
- 229960000366 emtricitabine Drugs 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- LDEKQSIMHVQZJK-CAQYMETFSA-N tenofovir alafenamide Chemical compound O([P@@](=O)(CO[C@H](C)CN1C2=NC=NC(N)=C2N=C1)N[C@@H](C)C(=O)OC(C)C)C1=CC=CC=C1 LDEKQSIMHVQZJK-CAQYMETFSA-N 0.000 abstract 1
- 229960004946 tenofovir alafenamide Drugs 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención proporciona una forma de dosificación oral sólida que comprende alafenamida de tenofovir o una sal farmacéuticamente aceptable de la misma, y emtricitabina o una sal farmacéuticamente aceptable de la misma.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562187113P | 2015-06-30 | 2015-06-30 | |
| US201662298373P | 2016-02-22 | 2016-02-22 | |
| US201662317286P | 2016-04-01 | 2016-04-01 | |
| PCT/US2016/040158 WO2017004244A1 (en) | 2015-06-30 | 2016-06-29 | Pharmaceutical formulations comprising tenofovir and emtricitabine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20170601A true CR20170601A (es) | 2018-02-28 |
Family
ID=61730529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20170601A CR20170601A (es) | 2015-06-30 | 2016-06-29 | Formulaciones farmaceuticas que comprenden tenofovir y emtricitabina |
Country Status (1)
| Country | Link |
|---|---|
| CR (1) | CR20170601A (es) |
-
2016
- 2016-06-29 CR CR20170601A patent/CR20170601A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017013293A2 (es) | Formulaciones farmacéuticas que comprenden tenofovir y emtricitabina | |
| IL264210A (en) | High-strength oral cannabinoid dosage forms | |
| MX2017016802A (es) | Formulaciones farmaceuticas. | |
| EP4045480A4 (en) | PHARMACEUTICAL FORMULATIONS | |
| IL258464A (en) | Pharmaceutical compositions for oral administration of peptide drugs | |
| IL264065A (en) | Oral gastroretentive formulations and uses thes thereof | |
| EP3541385A4 (en) | PHARMACEUTICAL FORMULATIONS | |
| PH12016501841A1 (en) | Immunosuppressant formulation | |
| HUP1700253A1 (hu) | Szilárd orális gyógyszerkészítmények | |
| MA55015A (fr) | Formulations pharmaceutiques | |
| ZA202006570B (en) | Pharmaceutical formulations | |
| EP3383397A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH DORAVIRIN, TENOFOVIR DISOPROXIL FUMARATE AND LAMIVUDIN | |
| PL3326619T3 (pl) | Stałe doustne kompozycje farmaceutyczne zawierające tenofowir i emtrycytabinę | |
| EP3746080A4 (en) | PHARMACEUTICAL FORMULATIONS | |
| MX385513B (es) | Composiciones farmaceuticas que comprenden safinamida. | |
| SG11202010792TA (en) | Improved pharmaceutical formulations | |
| EP3697393A4 (en) | DOSAGE FORMS | |
| EP3651800C0 (en) | HYDROCOMPRESSED PHARMACEUTICAL FORMULATIONS | |
| CR20170601A (es) | Formulaciones farmaceuticas que comprenden tenofovir y emtricitabina | |
| ZA201804275B (en) | Oral pharmaceutical composition comprising taste-masked n-acetylcysteine | |
| JOP20170198A1 (ar) | صيغ صيدلية تشتمل على تينوفوفير و إيمترايسيتابين | |
| HUE056233T2 (hu) | Ibuprofén készítmények közvetlen orális beadásra | |
| CY1123966T1 (el) | Διαδικασια για την παρασκευη νατριουχου εποπροστενολης ενισχυμενης σταθεροτητας | |
| TR201721065A2 (tr) | Deksmedetomi̇di̇n i̇çeren li̇yofi̇li̇ze farmasöti̇k formülasyonlar | |
| TH1501007612A (th) | อมอร์ฟัสลีเทอร์โมเวียร์และสูตรผสมของแข็งทางเภสัชกรรมของมันสำหรับให้เข้าทางปาก |